IL1A and neoplasm: Recently, breast tumor-derived IL-1α was reported to act on tumor-infiltrating myeloid cells inducing the expression of thymic stromal lymphopoietin (TSLP), a factor that was crucial for tumor survival and metastatic spreading [32].